These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 36502288)

  • 21. The Role of the Pharmacist in Managing Type 2 Diabetes with Glucagon-Like Peptide-1 Receptor Agonists as Add-On Therapy.
    Meece J
    Adv Ther; 2017 Mar; 34(3):638-657. PubMed ID: 28210986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered glucose metabolism after bariatric surgery: What's GLP-1 got to do with it?
    Smith EP; Polanco G; Yaqub A; Salehi M
    Metabolism; 2018 Jun; 83():159-166. PubMed ID: 29113813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucagon-like Peptide-1 Receptor Agonists: A Class Update for Treating Type 2 Diabetes.
    Lovshin JA
    Can J Diabetes; 2017 Oct; 41(5):524-535. PubMed ID: 28942790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-like growth factor 1 predicts post-load hypoglycemia following bariatric surgery: a prospective cohort study.
    Itariu BK; Zeyda M; Prager G; Stulnig TM
    PLoS One; 2014; 9(4):e94613. PubMed ID: 24736741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laparoscopic Conversion of Roux-en-Y Gastric Bypass to Sleeve Gastrectomy for Postprandial Hyperinsulinemic Hypoglycemia.
    Dar R; Hershko D; Nevo HA; Mokary SE; Sakran N
    Obes Surg; 2020 Mar; 30(3):1171-1172. PubMed ID: 31853867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GLP-1 receptor agonists in the treatment of type 2 diabetes: role and clinical experience to date.
    Brunton SA; Wysham CH
    Postgrad Med; 2020 Nov; 132(sup2):3-14. PubMed ID: 32815454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous glucose monitoring reveals glycemic variability and hypoglycemia after vertical sleeve gastrectomy in rats.
    Evers SS; Kim KS; Bozadjieva N; Lewis AG; Farris D; Sorensen MJ; Kim Y; Whitesall SE; Kennedy RT; Michele DE; Seeley RJ; Sandoval DA
    Mol Metab; 2020 Feb; 32():148-159. PubMed ID: 32029224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and Acceptability of Glycemic Control of Glucagon-Like Peptide-1 Receptor Agonists among Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.
    Li Z; Zhang Y; Quan X; Yang Z; Zeng X; Ji L; Sun F; Zhan S
    PLoS One; 2016; 11(5):e0154206. PubMed ID: 27158818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GLP-1 receptor agonists and risk of cancer in type 2 diabetes: an updated meta-analysis of randomized controlled trials.
    Cao C; Yang S; Zhou Z
    Endocrine; 2019 Nov; 66(2):157-165. PubMed ID: 31420784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of glucagon-like peptide-1 receptor agonists on glycemic control and anthropometric profiles among diabetic patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Nowrouzi-Sohrabi P; Rezaei S; Jalali M; Ashourpour M; Ahmadipour A; Keshavarz P; Akbari H
    Eur J Pharmacol; 2021 Feb; 893():173823. PubMed ID: 33352183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoglycemia following the use of glucagon-like peptide-1 receptor agonists: a real-world analysis of post-marketing surveillance data.
    Zhao Z; Tang Y; Hu Y; Zhu H; Chen X; Zhao B
    Ann Transl Med; 2021 Sep; 9(18):1482. PubMed ID: 34734034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucagon-like peptide 1 (GLP-1) drives postprandial hyperinsulinemic hypoglycemia in pregnant women with a history of Roux-en-Y gastric bypass operation.
    Leutner M; Klimek P; Göbl C; Bozkurt L; Harreiter J; Husslein P; Eppel W; Baumgartner-Parzer S; Pacini G; Thurner S; Kautzky-Willer A
    Metabolism; 2019 Feb; 91():10-17. PubMed ID: 30448278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fixed-Ratio Combinations of Basal Insulin and GLP-1RA in the Management of Type 2 Diabetes Mellitus: Highlights from the Literature.
    Lisco G; De Tullio A; Guastamacchia E; Triggiani V
    Endocr Metab Immune Disord Drug Targets; 2021; 21(4):626-646. PubMed ID: 32628602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Impact of Bariatric Surgery on Type 2 Diabetes Mellitus and the Management of Hypoglycemic Events.
    Kassem MA; Durda MA; Stoicea N; Cavus O; Sahin L; Rogers B
    Front Endocrinol (Lausanne); 2017; 8():37. PubMed ID: 28298900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acarbose improves hypoglycaemia following gastric bypass surgery without increasing glucagon-like peptide 1 levels.
    Valderas JP; Ahuad J; Rubio L; Escalona M; Pollak F; Maiz A
    Obes Surg; 2012 Apr; 22(4):582-6. PubMed ID: 22161170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk factors: A narrative review of head-to-head comparisons.
    Dalsgaard NB; Vilsbøll T; Knop FK
    Diabetes Obes Metab; 2018 Mar; 20(3):508-519. PubMed ID: 29024408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and tolerability of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A systematic review and network meta-analysis.
    Hussein H; Zaccardi F; Khunti K; Davies MJ; Patsko E; Dhalwani NN; Kloecker DE; Ioannidou E; Gray LJ
    Diabetes Obes Metab; 2020 Jul; 22(7):1035-1046. PubMed ID: 32077218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incretin mimetics and sodium-glucose co-transporter 2 inhibitors as monotherapy or add-on to metformin for treatment of type 2 diabetes: a systematic review and network meta-analysis.
    Jia S; Wang Z; Han R; Zhang Z; Li Y; Qin X; Zhao M; Xiang R; Yang J
    Acta Diabetol; 2021 Jan; 58(1):5-18. PubMed ID: 32514989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postprandial hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: an update.
    Øhrstrøm CC; Worm D; Hansen DL
    Surg Obes Relat Dis; 2017 Feb; 13(2):345-351. PubMed ID: 27865808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.